Cargando…

Integrated genomic analysis to identify druggable targets for pancreatic cancer

According to the National Comprehensive Cancer Network and the American Society of Clinical Oncology, the standard treatment for pancreatic cancer (PC) is gemcitabine and fluorouracil. Other chemotherapeutic agents have been widely combined. However, drug resistance remains a huge challenge, leading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mugiyanto, Eko, Adikusuma, Wirawan, Irham, Lalu Muhammad, Huang, Wan-Chen, Chang, Wei-Chiao, Kuo, Chun-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752886/ https://www.ncbi.nlm.nih.gov/pubmed/36531045 http://dx.doi.org/10.3389/fonc.2022.989077

Ejemplares similares

Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
por: Adikusuma, Wirawan, et al.
Publicado: (2022)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Integrated genomic network analysis revealed potential of a druggable target for hemorrhoid treatment
por: Adikusuma, Wirawan, et al.
Publicado: (2023)

Identification of druggable genes for multiple myeloma based on genomic information
por: Satria, Rahmat Dani, et al.
Publicado: (2023)

Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis
por: Zazuli, Zulfan, et al.
Publicado: (2022)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents
por: Irham, Lalu Muhammad, et al.
Publicado: (2020)

Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis
por: Irham, Lalu Muhammad, et al.
Publicado: (2023)

A bioinformatic approach to identify pathogenic variants for Stevens-Johnson syndrome
por: Ma’ruf, Muhammad, et al.
Publicado: (2023)

Bioinformatics Analysis to Uncover the Potential Drug Targets Responsible for Mycobacterium tuberculosis Peptidoglycan and Lysine Biosynthesis
por: Ayu Eka Pitaloka, Dian, et al.
Publicado: (2023)

Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection
por: Muhammad Irham, Lalu, et al.
Publicado: (2020)

Identification of Hub Genes and Potential Biomarkers for Childhood Asthma by Utilizing an Established Bioinformatic Analysis Approach
por: Santri, Ichtiarini Nurullita, et al.
Publicado: (2022)

Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer
por: Adikusuma, Wirawan, et al.
Publicado: (2023)

Genetic Association of the Functional WDR4 Gene in Male Fertility
por: Wang, Yu-Jia, et al.
Publicado: (2021)

The use of genomic variants to drive drug repurposing for chronic hepatitis B
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Identifying pathogenic variants related to systemic lupus erythematosus by integrating genomic databases and a bioinformatic approach
por: Yudhani, Ratih Dewi, et al.
Publicado: (2023)

p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
por: Yang, Ling, et al.
Publicado: (2019)

Investigation of susceptibility genes for chickenpox disease across multiple continents
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

MiR-22 as a metabolic silencer and liver tumor suppressor
por: Wang, Lijun, et al.
Publicado: (2020)

Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing
por: van den Heuvel, Corina N. A. M., et al.
Publicado: (2019)

An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets
por: Radusky, Leandro G, et al.
Publicado: (2015)

The Effect of Education through Short Message Service (SMS) Messages on Diabetic Patients Adherence
por: Adikusuma, Wirawan, et al.
Publicado: (2017)

Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a “non-druggable” target, STAT3 N-terminal domain
por: Bonilla, Pedro Andrade, et al.
Publicado: (2023)

Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study
por: Irham, Lalu Muhammad, et al.
Publicado: (2019)

Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable Target
por: Desai, Sagar Sanjiv, et al.
Publicado: (2021)

Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers
por: Schlein, Lisa J., et al.
Publicado: (2019)

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease
por: Su, Wei-Ming, et al.
Publicado: (2023)

Identifying Druggable Targets by Protein Microenvironments Matching: Application to Transcription Factors
por: Liu, T, et al.
Publicado: (2014)

p53 as a biomarker and potential target in gastrointestinal stromal tumors
por: Wu, Chiao-En, et al.
Publicado: (2022)

Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas
por: van de Geer, Wesley S, et al.
Publicado: (2021)

Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
por: Chen, Yi-Lun, et al.
Publicado: (2022)

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
por: Silva Barcelos, Estevão Carlos, et al.
Publicado: (2023)

siRNA screen identifies QPCT as a druggable target for Huntington’s disease
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2015)

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
por: Zhou, Yujia, et al.
Publicado: (2020)

A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy
por: Wierer, Michael, et al.
Publicado: (2021)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer
por: Fujii, Atsushi, et al.
Publicado: (2021)

Mitochondrial Potassium Channels as Druggable Targets
por: Wrzosek, Antoni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_arcfc4fma5p03bhurqgitsei77